KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Return on Assets (2018 - 2025)

Aquestive Therapeutics (AQST) has 8 years of Return on Assets data on record, last reported at 0.52% in Q4 2025.

  • For Q4 2025, Return on Assets fell 10.0% year-over-year to 0.52%; the TTM value through Dec 2025 reached 0.52%, down 10.0%, while the annual FY2025 figure was 0.64%, 8.0% down from the prior year.
  • Return on Assets reached 0.52% in Q4 2025 per AQST's latest filing, up from 0.54% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.13% in Q4 2023 and bottomed at 1.17% in Q1 2022.
  • Average Return on Assets over 5 years is 0.61%, with a median of 0.54% recorded in 2025.
  • Peak YoY movement for Return on Assets: fell -30bps in 2022, then soared 86bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 0.86% in 2021, then dropped by -16bps to 1.0% in 2022, then surged by 87bps to 0.13% in 2023, then plummeted by -210bps to 0.42% in 2024, then fell by -24bps to 0.52% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.52% in Q4 2025, 0.54% in Q3 2025, and 0.66% in Q2 2025.